GEN1119
/ Genmab
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 11, 2026
A Phase 1 Trial of GEN1119 in Participants With Solid Tumors
(clinicaltrials.gov)
- P1 | N=112 | Not yet recruiting | Sponsor: Genmab
First-in-human • New P1 trial • Oncology • Solid Tumor
September 04, 2026
A Phase 1 Trial of GEN1119 in Participants With Solid Tumors
(clinicaltrials.gov)
- P1 | N=112 | Recruiting | Sponsor: Genmab | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1